The predominance of CD103+CD39+CD8+ TRM cells in CRLM relative to the liver ex vivo and their response to cognate antigens in vitro encouraged us to assess their responses directed against the tumor rather than pathogen-based peptide antigens. This evidence concerns the gene CD8A and neoplasm.